🫀 Real Cardiovascular Risk

For everyone · 9 markers · $187.60 with code CAMERON $208.45

Anyone over 30, anyone with a family history of early heart disease, or anyone who's been told their cholesterol is 'fine' and wants to know what that actually means.

🩸 Order this exact panel — 10% off

All 9 markers load into your cart in one click. No doctor's visit, drawn at any Quest location in the US, results by email in about two weeks. Code CAMERON applies automatically.

Add all 9 markers — $187.60 → Open the full Bloodwork Vault →

Why this panel

Standard cholesterol panels measure the wrong thing. Risk is driven by the number of atherogenic particles, not the amount of cholesterol they carry. This panel measures particle count, the genetic risk factor almost nobody tests, and the inflammatory markers that determine whether plaque becomes an event.

💡 What most people missApoB beats LDL-C, and the two disagree often enough to matter. Every atherogenic particle carries exactly one ApoB molecule, so ApoB is a direct particle count. Someone with small dense LDL can have a reassuring LDL-C and a genuinely dangerous ApoB — this is called discordance and it's common in insulin-resistant people. The bigger omission is Lp(a): it's almost entirely genetic, it multiplies risk substantially, roughly 20% of people have an elevated level, and virtually none of them know because it isn't on a standard panel. You only ever need to measure it once in your life.
⏰ When to get it drawnFast 9–12 hours for accurate triglycerides. Lp(a) is genetic — once is enough, ever.

What this panel can settle, and by what logic

Nine markers, and the reason to buy them together is that four of them disagree with each other in a way a standard cholesterol panel cannot show you.

  1. ApoB (Apolipoprotein B) against the Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) settles discordance. Every atherogenic particle carries one apolipoprotein B molecule, so ApoB is a count and LDL cholesterol is a cargo weight. In statin-treated patients, ApoB and non-HDL cholesterol reflected the residual risk that remained better than LDL cholesterol did Johannesen 2021. The practical version: an LDL cholesterol of 95 mg/dL with an ApoB of 115 mg/dL is a worse result than the LDL number alone reads, and this panel is one of the few places you can see both at once.
  2. Lipoprotein(a) — Lp(a) settles a question you only get to ask once. It is largely genetically determined, so a single measurement stands for life, and it is the reason routine testing has been argued for at all Nurmohamed 2023. An elevated Lp(a) does not change your LDL number; it changes how hard the LDL number needs to be pushed.
  3. Apolipoprotein A-1 beside ApoB turns two absolute numbers into a ratio. ApoA-1 counts the particles carrying cholesterol away and ApoB (Apolipoprotein B) counts the ones delivering it, so the balance between them is a different statement from either count on its own.
  4. HbA1c (Hemoglobin A1c) and Fasting Insulin explain the lipid result rather than adding to it. Insulin resistance is what produces the small dense particle pattern that makes ApoB run ahead of LDL cholesterol, so a discordant lipid panel with a fasting insulin of 14 µIU/mL is one finding, not two.

hs-CRP (High-Sensitivity C-Reactive Protein) and Lp-PLA2 Activity are also not duplicates: one is systemic inflammatory tone from any source, the other is vascular-specific. A high hs-CRP with a normal Lp-PLA2 usually points somewhere other than the artery wall.

What it cannot settle, and what would

It cannot see plaque, and plaque is the disease. Everything here measures the drivers of atherosclerosis; none of it measures whether atherosclerosis has happened. That is what a coronary artery calcium score is for, and it is not a small addition: in two cohorts, the calcium score discriminated coronary heart disease events better than a polygenic risk score did Khan 2023. It is a low-dose CT costing about $100, and position statements place it in people at intermediate calculated risk, where it changes what happens next Jennings 2021. If you are over 45 and want the one test this panel does not contain, that is the test.

A normal lipid panel with a high Lipoprotein(a) — Lp(a) is not a normal risk. This is the specific way people misread these nine results. Lp(a) travels independently of the rest of the panel, so it is entirely possible to hold an ApoB of 70 mg/dL, an hs-CRP of 0.5 mg/L and a genuinely elevated Lp(a) Nurmohamed 2023. Nothing else on the list will hint at it.

It cannot produce a risk estimate on its own. Every cardiovascular risk equation in use runs on age, sex, blood pressure, smoking status and diabetes alongside the lipids. A panel with no blood pressure reading in it cannot output a percentage, and a page that implied otherwise would be inventing one Jennings 2021.

And it cannot tell you that Homocysteine is causing anything. Homocysteine is measured here as an association, and lowering it with B vitamins has repeatedly failed to convert into fewer events. A raised value is a prompt to look at Vitamin B12 and Folate, Serum status, which this panel does not contain, rather than a target in its own right.

Draw conditions that decide whether the money is wasted

Only three things on this list can be spoiled, and one of them cannot be spoiled at all.

  1. Fast 9 to 12 hours, for the triglycerides specifically. Triglycerides are the one lipid that follows the last meal, and on most reports LDL cholesterol is not measured but calculated from them, so a non-fasting draw corrupts two lines rather than one. ApoB (Apolipoprotein B) is measured rather than derived, and it is also the number that tracked residual risk better than LDL cholesterol did Johannesen 2021, so it is the one to trust when the fast was imperfect.
  2. Do not draw hs-CRP (High-Sensitivity C-Reactive Protein) within 2 weeks of an infection or 48 hours of a hard session. It is an acute-phase protein and a transient rise is indistinguishable on the report from the chronic low-grade elevation that carries the risk Luo 2023. A CRP of 6 mg/L drawn 3 days after a chest infection is a number about the infection.
  3. Lipoprotein(a) — Lp(a) does not care about any of this. Fasted, fed, trained, ill — it is the same result, which is why it is the one marker here you should buy without planning around Nurmohamed 2023.
  4. HbA1c (Hemoglobin A1c) is a red blood cell measurement as much as a glucose one. Its value depends on red cell lifespan and on globin chain structure as well as on blood sugar Chen 2022, so an HbA1c drawn during recovery from blood loss, or in someone with a hemoglobin variant, reads low for reasons that have nothing to do with risk.

How you would know it answered your question, and what each pattern means next

Four results, four different next steps, and only two of them are another blood test.

  • ApoB (Apolipoprotein B) above 90 mg/dL: the number to move, because it is the one that reflected what risk was left over after treatment Johannesen 2021. Retest 8 to 12 weeks after any real change in diet or medication: hepatic lipoprotein production resets over weeks, and a 3-week draw catches the transition rather than the new level.
  • Lipoprotein(a) — Lp(a) elevated: never repeat it. What changes is the target for everything else, and this is the result that most often justifies going and getting a calcium score rather than another panel Nurmohamed 2023 Jennings 2021.
  • hs-CRP (High-Sensitivity C-Reactive Protein) above 2 mg/L with everything else clean: repeat it once, at least 2 weeks clear of illness and training, before believing it Luo 2023. Chronic elevation is a finding; a single high value is usually a week.
  • Everything optimal and a family history of early events: this panel has told you what it can. The next spend is imaging, not repetition — a calcium score of zero and a calcium score of 300 are entirely compatible with the results you are holding Khan 2023.

Sources read for these sections

  • Johannesen CDL, et al. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients. Journal of the American College of Cardiology 2021 · PMID 33736827
  • Nurmohamed NS, et al. Considerations for routinely testing for high lipoprotein(a). Current Opinion in Lipidology 2023 · PMID 35942815
  • Khan SS, et al. Coronary Artery Calcium Score and Polygenic Risk Score for the Prediction of Coronary Heart Disease Events. JAMA 2023 · PMID 37219552
  • Jennings GL, et al. National Heart Foundation of Australia: position statement on coronary artery calcium scoring for the primary prevention of cardiovascular disease in Australia. Medical Journal of Australia 2021 · PMID 33960402
  • Luo H, et al. A Practical Guide to Adjust Micronutrient Biomarkers for Inflammation Using the BRINDA Method. Journal of Nutrition 2023 · PMID 36792034
  • Chen Z, et al. Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review). Experimental and Therapeutic Medicine 2022 · PMID 36382101

The 9 markers — and why each one is here

ApoB (Apolipoprotein B) $20.00
The particle count. Better than LDL-C, and they disagree more than you'd expect
Lipoprotein(a) — Lp(a) $32.50
Genetic, powerful, once in a lifetime — and almost never ordered
Lipid Panel $9.00
Standard lipids for context and the Trig:HDL ratio
Apolipoprotein A-1 $29.00
The protective side; the ApoB:ApoA-1 ratio is strongly predictive
hs-CRP (C-Reactive Protein, High Sensitivity) $18.50
Inflammation determines whether plaque ruptures
Homocysteine $20.45
Independent vascular risk factor, and correctable with B vitamins
HbA1c (Hemoglobin A1c) $9.00
Glycemic control is inseparable from vascular risk
Insulin (Fasting) $10.00
Insulin resistance drives the small dense LDL pattern
Lp-PLA2 Activity $60.00
Vascular-specific inflammation — more targeted than CRP
✓ How to read the resultsApoB is the number to track; under 80 mg/dL is a common optimization target and under 60 for established disease. Lp(a) above ~50 mg/dL (or 125 nmol/L) means your other risk factors need to be managed harder — it isn't itself very modifiable. hs-CRP above 2 suggests inflammatory risk on top of lipid risk.
🔒 The Cardiovascular Risk protocol is inside Skool

Ordering the panel tells you your numbers. The protocol tells you what to do with them — why a normal cholesterol panel can hide real risk, the one marker that counts what actually causes plaque, the genetic test to run once in your life and tell your family about, and an honest read on the supplement that is secretly a statin.

Join Skool — $10/mo →

What this panel is ordered to decide

A panel is a set of numbers until it settles something. These are the decisions this one feeds — each links the pathway it belongs to, what that pathway claims, and what its test list is read for.

🫀 ApoB & LDL particle reduction Heart, cholesterol & blood pressure
ApoB counts atherogenic particles; LDL-C estimates the cholesterol inside them. When the two disagree — common in insulin resistance — ApoB is right and LDL-C is falsely reassuring.
❤️‍🔥 Vascular & erectile function Libido & sexual function
Erectile dysfunction is an early cardiovascular symptom — the penile arteries are narrower than the coronaries and narrow first, typically three to five years ahead. Treat this as a heart finding, because it is one.
🫀 Endothelial function & nitric oxide Heart, cholesterol & blood pressure
ADMA inhibits nitric oxide synthase directly, so it is the most specific endothelial marker available. Dysfunction here precedes visible plaque by decades.
🧬 Vascular, cardiac & structural Organ-specific bioregulation
Vascular and cardiac endpoints are measurable, which makes this the easiest place to hold the bioregulator claims to account. Baseline first.
🫀 Cardiac energetics & heart failure support Heart, cholesterol & blood pressure
Statins deplete CoQ10 through the same enzyme they inhibit, which is the mechanistic basis for co-supplementing. Thyroid is on this list because both directions cause cardiomyopathy.
Not quite the combination you wanted? Build it in the panel comparer — pick the markers you actually want and it prices the cheapest panel that covers them against buying the same tests one at a time, with the code applied to both.

Frequently asked questions

What blood tests are in the real cardiovascular risk panel?

9 markers: ApoB (Apolipoprotein B), Lipoprotein(a) — Lp(a), Lipid Panel, Apolipoprotein A-1, hs-CRP (C-Reactive Protein, High Sensitivity), Homocysteine, HbA1c (Hemoglobin A1c), Insulin (Fasting), Lp-PLA2 Activity.

How much does the real cardiovascular risk panel cost?

$208.45 before discount, $187.60 with code CAMERON applied automatically. Individual markers add a one-time $10 draw fee. Ordered through Marek Diagnostics and drawn at any Quest Diagnostics location in the US.

Do I need a doctor's order for these tests?

No. These are ordered direct-to-consumer through Marek Diagnostics — you order online, walk into a Quest location, and results are emailed to you in about two weeks. No physician visit or insurance required. Not available in NY, NJ or RI.

When should I get the real cardiovascular risk panel drawn?

Fast 9–12 hours for accurate triglycerides. Lp(a) is genetic — once is enough, ever.

How do I interpret Real Cardiovascular Risk results?

ApoB is the number to track; under 80 mg/dL is a common optimization target and under 60 for established disease. Lp(a) above ~50 mg/dL (or 125 nmol/L) means your other risk factors need to be managed harder — it isn't itself very modifiable. hs-CRP above 2 suggests inflammatory risk on top of lipid risk.

Where this goes next

The full protocol$10/mo

This page is how to read the panel. What to DO about each result — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.

Important: This page is education only, not medical advice and not a diagnosis. A panel is a starting point for a conversation with a clinician, not a substitute for one. Reference ranges vary by laboratory and assay — always compare against the range printed on your own report.

↑ Back to on this page